Brompheniramine, pseudoephedrine, and dextromethorphan vs CYP2D6 Inhibitors (Strong)

Interacting Drugs
Brompheniramine, pseudoephedrine, and dextromethorphan
vs
CYP2D6 Inhibitors (Strong)
Security Level
Moderate, Consider therapy modification
Mechanism
CYP2D6 Inhibitors (Strong): May decrease the metabolism of CYP2D6 Substrates.
Management
Consider therapy modification

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Brompheniramine, pseudoephedrine, and dextromethorphan vs CYP2D6 Inhibitors (Strong)


Other Interactions of Brompheniramine, pseudoephedrine, and dextromethorphan
Interaction
Minor, Monitor Therapy Brompheniramine, pseudoephedrine, and dextromethorphan vs Tocilizumab
Minor, Monitor Therapy Brompheniramine, pseudoephedrine, and dextromethorphan vs Sympathomimetics
Minor, Monitor Therapy Brompheniramine, pseudoephedrine, and dextromethorphan vs Spironolactone
Major, Avoid combination Brompheniramine, pseudoephedrine, and dextromethorphan vs Sibutramine
Moderate, Consider therapy modification Brompheniramine, pseudoephedrine, and dextromethorphan vs Serotonin/Norepinephrine Reuptake Inhibitors
Moderate, Consider therapy modification Brompheniramine, pseudoephedrine, and dextromethorphan vs Serotonin Modulators
Moderate, Consider therapy modification Brompheniramine, pseudoephedrine, and dextromethorphan vs Selective Serotonin Reuptake Inhibitors
Moderate, Consider therapy modification Brompheniramine, pseudoephedrine, and dextromethorphan vs QuiNIDine
Moderate, Consider therapy modification Brompheniramine, pseudoephedrine, and dextromethorphan vs Pramlintide
Minor, Monitor Therapy Brompheniramine, pseudoephedrine, and dextromethorphan vs Peginterferon Alfa-2b
Pages: 1 2 3 4 Next
Other Interactions of CYP2D6 Inhibitors (Strong)
Interaction
Moderate, Consider therapy modification Butalbital compound and codeine vs CYP2D6 Inhibitors (Strong)
Moderate, Consider therapy modification Amitriptyline and perphenazine vs CYP2D6 Inhibitors (Strong)
Moderate, Consider therapy modification Lidocaine and hydrocortisone vs CYP2D6 Inhibitors (Strong)
Moderate, Consider therapy modification Lidocaine (systemic) vs CYP2D6 Inhibitors (Strong)
Moderate, Consider therapy modification Acetaminophen and codeine vs CYP2D6 Inhibitors (Strong)
Moderate, Consider therapy modification Doxepin (topical) vs CYP2D6 Inhibitors (Strong)
Moderate, Consider therapy modification Methamphetamine vs CYP2D6 Inhibitors (Strong)
Moderate, Consider therapy modification Tetrabenazine vs CYP2D6 Inhibitors (Strong)
Moderate, Consider therapy modification Flecainide vs CYP2D6 Inhibitors (Strong)
Moderate, Consider therapy modification Doxepin (systemic) vs CYP2D6 Inhibitors (Strong)
Pages: 1 2 3 4 5 6 7 8 9 10 Next